Dear All,
Please note that the pro forma tables, excluding the blood transfusion diagnostics unit, are now available at
http://www.novartis.com/investors/financial-results/quarterly-results-q4-2013.shtml
With kind Regards
Novartis Investor Relations
| Novartis Global Investor Relations, General phone | +41 61 324 79 44 | ||
| Dr. Samir Shah, Global Head Investor Relations | +41 61 324 79 44 | ||
| Basel Office | North Amerian Office | ||
| Pierre-Michel Bringer | +41 61 324 10 65 | Stephen Rubino | +1 862 778 83 01 |
| Thomas Hungerbuehler | +41 61 324 84 25 | Jill Pozarek | +1 212 830 24 45 |
| Isabella Zinck | +41 61 324 71 88 | Susan Donofrio | +1 862 778 92 57 |